RxDoctor Payments Data

Scott Gurwin

Podiatrist · Gahanna, OHNPI 1386640332

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.6% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Stryker accounts for 87.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $1,800 and has fallen 87.4% since, to $227 in 2025.

$6,696in general payments, 2019–2025

Across 75 payments — averaging $89.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$6K
  • Organogenesis Inc.$188
  • Angiodynamics, Inc.$122
  • Arthrex$106
  • Smith+Nephew$92
  • Pfizer$86
  • plus $265 from 7 others

What the payments were for

  • Food & beverage$6,60199%
  • Gifts$951%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,696 in reported general payments places this provider in the 85th percentile of 397 podiatrist providers in Ohio.

See all podiatrist providers in Ohio

Medicare billing

Part B allowed, 2024
$122,306
Medicare patients
737
Services billed
2,385

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin151$1,603
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip11$656
Ketoconazole26$633
Gentamicin Sulfate12$581
Pregabalin13$502
Clotrimazole28$453
Terbinafine Hcl20$281
Ammonium Lactate23$264
Doxycycline Hyclate23$230
Diclofenac Sodium21$195
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$163
Prednisone23$36

Paid to pharmacies, not to this prescriber.

Other podiatrist in Gahanna

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →